THROMBOTIC MICROANGIOPATHY side effect
What is THROMBOTIC MICROANGIOPATHY ?Drugs associated with THROMBOTIC MICROANGIOPATHY
ALKERAN AVASTIN BETAFERON BEVACIZUMAB BUSULFAN CAELYX CAPECITABINE CELLCEPT CERTICAN CYCLOPHOSPHAMIDE CYCLOSPORINE DOXORUBICIN FLUDARA FUNGUARD GEMZAR IBUPROFEN NEORAL NOVANTRONE PEGASYS PROGRAF RAPAMUNE SPRYCEL SUTENT VELCADETHROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5672356-3
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Mar 11, 2008. Male patient, 74 years of age, was diagnosed with hepatic neoplasm malignant, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 7.5 MG/KG, Q2W. During the same period patient was treated with AMLODIPINE. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5672365-4
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 11, 2008. Male patient, 62 years of age, was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with CISPLATIN, TAXOTERE, CYTOXAN. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Avastin Side Effects Report #5672561-6
Physician from CANADA reported AVASTIN problem on Mar 11, 2008. Female patient, 59 years of age, was diagnosed with ovarian cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . AVASTIN dosage: 15 MG/KG, Q3W. Patient died.
THROMBOTIC MICROANGIOPATHY : Avastin Side Effects Report #5676211-4
AVASTIN problem was reported by a Physician from CANADA on Mar 14, 2008. Male patient, 61 years of age, was diagnosed with pancreatic carcinoma and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . AVASTIN dosage: 10 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Avastin Side Effects Report #5683422-0
Physician from CANADA reported AVASTIN problem on Mar 13, 2008. Female patient, 59 years of age, was diagnosed with ovarian cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . AVASTIN dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, CARBOPLATIN. Patient died.
THROMBOTIC MICROANGIOPATHY : Prograf Side Effects Report #5626157-2
PROGRAF problem was reported by a Physician from JAPAN on Jan 23, 2008. Male patient, 48 years of age, was diagnosed with liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . PROGRAF dosage: unknown. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5633639-6
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Feb 13, 2008. Male patient, 69 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUTENT. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5633650-5
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Feb 13, 2008. Female patient, 54 years of age, was diagnosed with metastatic renal cell carcinoma, headache, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUNITINIB MALATE, ALPRAZOLAM, ACETAMINOPHEN, OMEPRAZOLE, DOCUSATE, ALUMINUM MAGNESIUM CARBONATE HYDROXIDE, BISMUTH, NORVASC. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5633656-6
Physician from UNITED STATES reported BEVACIZUMAB problem on Feb 13, 2008. Male patient, 56 years of age, was diagnosed with metastatic renal cell carcinoma, hypothyroidism, hypertension, gastrooesophageal reflux disease and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUNITINIB MALATE, LEVOTHYROXINE, TRIAMTERENE AND HYDROCHLOROTHIAZIDE, FAMOTIDINE, AMLODIPINE, ESOMEPRAZOLE MAGNESIUM. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Alkeran Side Effects Report #5585595-7
ALKERAN problem was reported by a Physician from JAPAN on Jan 08, 2008. Female patient, 64 years of age, weighting 121.3 lb, was diagnosed with immunosuppression and was treated with ALKERAN. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . ALKERAN dosage: 70MGM2 PER DAY. During the same period patient was treated with FLUDARA, TACROLIMUS HYDRATE, METHOTREXATE, POLYMYXIN B SULPHATE, VANCOMYCIN HYDROCHLORIDE. Patient died on 03/19/2005.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5587232-4
Physician from UNITED STATES reported BEVACIZUMAB problem on Jan 04, 2008. Female patient, 54 years of age, was diagnosed with metastatic renal cell carcinoma, headache, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUNITINIB MALATE, ALPRAZOLAM, ACETAMINOPHEN, OMEPRAZOLE, DOCUSATE, ALUMINUM MAGNESIUM CARBONATE HYDROXIDE, BISMUTH, NORVASC. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5588243-5
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 08, 2008. Male patient, 69 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUTENT. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Rapamune Side Effects Report #5588471-9
Physician from GERMANY reported RAPAMUNE problem on Jan 10, 2008. Female patient was diagnosed with prophylaxis against transplant rejection and was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . RAPAMUNE dosage: unknown. During the same period patient was treated with GLUCOCORTICOIDS, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Cyclophosphamide Side Effects Report #5590365-X
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from on Jan 08, 2008. Male patient, 48 years of age, was diagnosed with immunosuppression and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with TACROLIMUS, MIZORIBINE, ANTITHROMBIN III, PROSTAGLANDIN I. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5591454-6
Physician from UNITED STATES reported BEVACIZUMAB problem on Jan 08, 2008. Female patient, 85 years of age, was diagnosed with renal cell carcinoma, insomnia, hypertension, hypersensitivity and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, UNK. During the same period patient was treated with SUNITINIB MALATE, SUNITINIB MALATE, LORAZEPAM, ASCORBIC ACID, CALCIUM, BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, FEXOFENADINE. Patient was hospitalized. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5593879-1
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 08, 2008. Female patient, 79 years of age, was diagnosed with metastatic renal cell carcinoma, anxiety and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with ACETAMINOPHEN, ALPRAZOLAM. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5593929-2
Physician from UNITED STATES reported BEVACIZUMAB problem on Jan 08, 2008. Male patient, 56 years of age, was diagnosed with metastatic renal cell carcinoma, hypothyroidism, hypertension, gastrooesophageal reflux disease and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUNITINIB MALATE, LEVOTHYROXINE, TRIAMTERENE AND HYDROCHLOROTHIAZIDE, FAMOTIDINE, AMLODIPINE, ESOMEPRAZOLE MAGNESIUM. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Sutent Side Effects Report #5596503-7
SUTENT problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 08, 2008. Female patient was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . SUTENT dosage: unknown. During the same period patient was treated with AVASTIN. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Sutent Side Effects Report #5596521-9
Consumer or non-health professional from UNITED STATES reported SUTENT problem on Jan 08, 2008. Female patient, 79 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . SUTENT dosage: unknown. During the same period patient was treated with AVASTIN, ACETAMINOPHEN, ALPRAZOLAM. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Sutent Side Effects Report #5596537-2
SUTENT problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 08, 2008. Female patient, 54 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . SUTENT dosage: DAILY DOSE:50MG-FREQ:DAILY. During the same period patient was treated with AVASTIN, ALPRAZOLAM, ACETAMINOPHEN, OMEPRAZOLE, DOCUSATE, ALMAGATE, BISMUTH, NORVASC. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Sutent Side Effects Report #5596605-5
Consumer or non-health professional from UNITED STATES reported SUTENT problem on Jan 08, 2008. Male patient, 56 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . SUTENT dosage: unknown. During the same period patient was treated with AVASTIN, LEVOTHYROXINE, TRIAMTERENE AND HYDROCHLOROTHIAZIDE, FAMOTIDINE, AMLODIPINE, ESOMEPRAZOLE MAGNESIUM. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Cyclophosphamide Side Effects Report #5535241-3
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from JAPAN on Dec 03, 2007. Male patient, 48 years of age, was diagnosed with immunosuppression and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . CYCLOPHOSPHAMIDE dosage: 1 FORM = 50-100 MG. During the same period patient was treated with TACROLIMUS, AZATHIOPRINE, MIZORIBINE. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Cyclophosphamide Side Effects Report #5553454-1
Health Professional from JAPAN reported CYCLOPHOSPHAMIDE problem on Dec 03, 2007. Male patient, 48 years of age, was diagnosed with immunosuppression and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . CYCLOPHOSPHAMIDE dosage: 1 FORM = 50-100 MG. During the same period patient was treated with TACROLIMUS, AZATHIOPRINE, MIZORIBINE. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5572237-X
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 14, 2007. Female patient was diagnosed with metastatic renal cell carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUTENT. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5572248-4
Physician from UNITED STATES reported BEVACIZUMAB problem on Dec 14, 2007. Female patient, 85 years of age, was diagnosed with insomnia, hypertension, hypersensitivity and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, UNK. During the same period patient was treated with SUNITINIB MALATE, SUNITINIB MALATE, LORAZEPAM, ASCORBIC ACID, CALCIUM, BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, FEXOFENADINE. Patient was hospitalized. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5572277-0
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Dec 14, 2007. Female patient, 56 years of age, was diagnosed with metastatic renal cell carcinoma, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUTENT, NORVASC, LANSOPRAZOLE. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5572278-2
Physician from UNITED STATES reported BEVACIZUMAB problem on Dec 14, 2007. Female patient, 54 years of age, was diagnosed with metastatic renal cell carcinoma, headache, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUNITINIB MALATE, ALPRAZOLAM, ACETAMINOPHEN, OMEPRAZOLE, DOCUSATE, ALUMINUM MAGNESIUM CARBONATE HYDROXIDE, BISMUTH, NORVASC. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5572283-6
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Dec 14, 2007. Male patient, 56 years of age, was diagnosed with metastatic renal cell carcinoma, hypothyroidism, hypertension, gastrooesophageal reflux disease and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUNITINIB MALATE, LEVOTHYROXINE, TRIAMTERENE AND HYDROCHLOROTHIAZIDE, FAMOTIDINE, AMLODIPINE, ESOMEPRAZOLE MAGNESIUM. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5572286-1
Physician from UNITED STATES reported BEVACIZUMAB problem on Dec 14, 2007. Female patient, 79 years of age, was diagnosed with metastatic renal cell carcinoma, anxiety and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with ACETAMINOPHEN, ALPRAZOLAM. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Pegasys Side Effects Report #5573078-X
PEGASYS problem was reported by a Physician from FRANCE on Dec 11, 2007. Male patient, 56 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . PEGASYS dosage: unknown. During the same period patient was treated with REBETOL, CALTRATE, CELECTOL, TAREG, KARDEGIC. Patient was hospitalized. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Pegasys Side Effects Report #5519986-7
Health Professional from FRANCE reported PEGASYS problem on Nov 06, 2007. Male patient, 56 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . PEGASYS dosage: unknown. During the same period patient was treated with REBETOL, CALTRATE, CELECTOL, VALSARTAN, KARDEGIC. Patient was hospitalized. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Fludara Side Effects Report #5495030-5
FLUDARA problem was reported by a Physician from JAPAN on Oct 10, 2007. Female patient, 46 years of age, was diagnosed with lupus nephritis, prophylaxis and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . FLUDARA dosage: unknown. During the same period patient was treated with CYCLOSPORINE, CAMPATH, CYCLOPHOSPHAMIDE. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Prograf Side Effects Report #5504525-7
Physician from JAPAN reported PROGRAF problem on Oct 16, 2007. Female patient, 17 years of age, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . PROGRAF dosage: unknown. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Capecitabine Side Effects Report #5442025-3
CAPECITABINE problem was reported by a Physician from AUSTRALIA on Aug 23, 2007. Female patient, 41 years of age, weighting 136.7 lb, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB, MITOMYCIN, PANTOPRAZOLE, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5467178-2
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Sept 13, 2007. Male patient, 59 years of age, was diagnosed with hepatic neoplasm malignant and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 7.5 MG/KG, Q2W. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5467209-X
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 13, 2007. Male patient, 56 years of age, was diagnosed with lung neoplasm malignant and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 15 MG/KG, Q3W. During the same period patient was treated with ALIMTA. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5467215-5
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Sept 13, 2007. Male patient, 62 years of age, was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with CISPLATIN, TAXOTERE, CYTOXAN. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Gemzar Side Effects Report #5411944-6
GEMZAR problem was reported by a Physician from UNITED STATES on Aug 03, 2007. Female patient, 33 years of age, was diagnosed with hodgkin's disease and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . GEMZAR dosage: unknown. During the same period patient was treated with VINORELBINE, DOXORUBICIN. Patient was hospitalized. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Alkeran Side Effects Report #5664504-6
Physician from JAPAN reported ALKERAN problem on Mar 10, 2008. Male patient, 40 years of age, was treated with ALKERAN. After drug was administered, patient experienced the following problems/side effects: hyperaesthesia, thrombotic microangiopathy, . ALKERAN dosage: 140MGM2 PER DAY. During the same period patient was treated with RANIMUSTINE, ETOPOSIDE, RITUXIMAB. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Sprycel Side Effects Report #5618778-8
SPRYCEL problem was reported by a Consumer or non-health professional from FRANCE on Feb 01, 2008. Male patient, 73 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with SPRYCEL. After drug was administered, patient experienced the following problems/side effects: confusional state, thrombotic microangiopathy, . SPRYCEL dosage: 03JAN08-10JAN08 140MG,11JAN08-16JAN08 280MG. During the same period patient was treated with VINCRISTINE, METHOTREXATE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5634009-7
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Feb 13, 2008. Female patient was diagnosed with metastatic renal cell carcinoma, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: microangiopathic haemolytic anaemia, thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUTENT, NORVASC, LANSOPRAZOLE. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Velcade Side Effects Report #5583736-9
VELCADE problem was reported by a Physician from JAPAN on Dec 17, 2007. Male patient, 54 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, thrombotic microangiopathy, thrombotic thrombocytopenic purpura, . VELCADE dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DECADRON. Patient was hospitalized. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5586978-1
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Jan 02, 2008. Female patient was diagnosed with metastatic renal cell carcinoma, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: microangiopathic haemolytic anaemia, thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUTENT, NORVASC, LANSOPRAZOLE. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Rapamune Side Effects Report #5588540-3
RAPAMUNE problem was reported by a Physician from GERMANY on Jan 10, 2008. Female patient was diagnosed with prophylaxis against transplant rejection and was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: kidney transplant rejection, thrombotic microangiopathy, . RAPAMUNE dosage: unknown. During the same period patient was treated with GLUCOCORTICOIDS, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Bevacizumab Side Effects Report #5592279-8
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Jan 08, 2008. Female patient was diagnosed with metastatic renal cell carcinoma, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: microangiopathic haemolytic anaemia, thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUTENT, NORVASC, LANSOPRAZOLE. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Sutent Side Effects Report #5596561-X
SUTENT problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 08, 2008. Female patient, 56 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: haemolytic anaemia, thrombotic microangiopathy, . SUTENT dosage: unknown. During the same period patient was treated with AVASTIN, NORVASC, LANSOPRAZOLE. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Sprycel Side Effects Report #5609094-9
Physician from FRANCE reported SPRYCEL problem on Jan 28, 2008. Male patient, 73 years of age, was diagnosed with chronic myeloid leukaemia and was treated with SPRYCEL. After drug was administered, patient experienced the following problems/side effects: thrombocytopenic purpura, thrombotic microangiopathy, . SPRYCEL dosage: unknown. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Fludara Side Effects Report #5550959-4
FLUDARA problem was reported by a Physician from JAPAN on Nov 29, 2007. Female patient, 46 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: proteinuria, thrombotic microangiopathy, . FLUDARA dosage: TOTAL DAILY DOSE: 28 MG. During the same period patient was treated with ALEMTUZUMAB, CYCLOPHOSPHAMIDE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Fludara Side Effects Report #5557368-2
Physician from JAPAN reported FLUDARA problem on Nov 29, 2007. Female patient, 46 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: proteinuria, thrombotic microangiopathy, . FLUDARA dosage: TOTAL DAILY DOSE: 28 MG. During the same period patient was treated with ALEMTUZUMAB, CYCLOPHOSPHAMIDE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Cyclosporine Side Effects Report #5476573-7
CYCLOSPORINE problem was reported by a Consumer or non-health professional from JAPAN on Sept 26, 2007. Female patient, 46 years of age, was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, thrombotic microangiopathy, . CYCLOSPORINE dosage: unknown. Patient recovered.
THROMBOTIC MICROANGIOPATHY : Neoral Side Effects Report #5478013-0
Consumer or non-health professional from JAPAN reported NEORAL problem on Oct 03, 2007. Male patient, 21 years of age, was diagnosed with bone marrow transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: infection, thrombotic microangiopathy, . NEORAL dosage: unknown. During the same period patient was treated with PREDNISOLONE, ANTITHYMOCYTE IMMUNOGLOBULIN. Patient died.